.@EricTopol @NatureNews @wilbanks Agree w/all. Only patient should own their data @Sagebio holds data for Rkit so it is part of this problem
-
-
-
2)
@ZibdyHealth@EricTopol@NatureNews@Sagebio e.g. participants decide if they want to donate a copy broadly, which 75% choose to do -
Tks
@wilbanks What happens if you find a blockbuster w/user data, do they get reach thru? can't do w/o data. -
.
@EricTopol@NatureNews@Sagebio@wilbanks Do users understand $$ implications upfront? Patients who donate get highest cost drugs, fair? -
.
@ZibdyHealth@EricTopol@NatureNews but a reach through model is something we’re looking at. still not sure how enforceable it is. -
.
@wilbanks@EricTopol@NatureNews Should be easy not a rocket science. Data donors should get bigger piece. -
.
@ZibdyHealth@EricTopol@NatureNews easy to write the contract. very difficult to enforce it effectively. especially in “open” context. -
.
@wilbanks@EricTopol@NatureNews Agree! This is why you are pioneering this. - 2 more replies
New conversation -
-
Be careful abt "donate data". Who monetizes this data for what? What is in it for the patient?
Thanks. Twitter will use this to make your timeline better. Undo -
-
Great job, per usual.
-
Thanks Ernesto!
End of conversation
New conversation -
-
.
@erictopol@naturenews@wilbanks@sagebio@nature disagree health data as ‘public good’ - first and foremost owned by individuals.Thanks. Twitter will use this to make your timeline better. Undo -
This would make
#Enlite a very dangerous device@EricTopol@NatureNews@wilbanks@Sagebio@nature@ScrippsSTSIpic.twitter.com/RdpANp8YGP
Thanks. Twitter will use this to make your timeline better. Undo -
Thanks. Twitter will use this to make your timeline better. Undo
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.